CNBC - The study has also helped us select a dose for our Phase 2 trial in general anxiety disorder scheduled to start in the United States later this year." tf.TFN-Europe_newsdesk@thomson.com hjp/jlw COPYRIGHT Copyright Thomson Financial News Limited ...